FDA Inspection 1278955 — Capzer Pharmaceuticals

Capzer Pharmaceuticals — FEI 3010165762

The FDA completed an inspection of Capzer Pharmaceuticals on July 24, 2025 in Lake Worth Beach, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 24, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lake Worth Beach, FL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
440421 CFR 211.194(a)(1)Sample identification and other information